Selected research
Industry Research
Risperidone Industry Research Report 2026
Market perspective
The global Risperidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Risperidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Risperidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Risperidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Risperidone include Ajanta Pharma, Amneal Pharmaceuticals, Apotex, Aurobindo Pharma, Celltrion, Dr. Reddy's Laboratories, Hikma, Lannett and Luye Pharma Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Risperidone market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Risperidone Market by Company
Ajanta Pharma
Amneal Pharmaceuticals
Apotex
Aurobindo Pharma
Celltrion
Dr. Reddy's Laboratories
Hikma
Lannett
Luye Pharma Group
Torrent Pharmaceuticals
Tris Pharma
Janssen (Johnson & Johnson)
Sandoz
Risperidone Segment by Type
Tablet
Oral Solution
Risperidone Segment by Application
Schizophrenia
Bipolar Disorder
Risperidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Risperidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Risperidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Risperidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Risperidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Risperidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Oral Solution
Applications
- Schizophrenia
- Bipolar Disorder
Companies covered
- Ajanta Pharma
- Amneal Pharmaceuticals
- Apotex
- Aurobindo Pharma
- Celltrion
- Dr. Reddy's Laboratories
- Hikma
- Lannett
- Luye Pharma Group
- Torrent Pharmaceuticals
- Tris Pharma
- Janssen (Johnson & Johnson)
- Sandoz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Risperidone Market Size (2021-2032)
- 2.2.2 Global Risperidone Sales (2021-2032)
- 2.2.3 Global Risperidone Market Average Price (2021-2032)
- 2.3 Risperidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Oral Solution
- 2.4 Risperidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Schizophrenia
- 2.4.3 Bipolar Disorder
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Risperidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Risperidone Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Risperidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Risperidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Risperidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Risperidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Risperidone, Product Type & Application
- 3.8 Global Manufacturers of Risperidone, Established Date
- 3.9 Global Risperidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ajanta Pharma
- 4.1.1 Ajanta Pharma Company Information
- 4.1.2 Ajanta Pharma Business Overview
- 4.1.3 Ajanta Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ajanta Pharma Risperidone Product Portfolio
- 4.1.5 Ajanta Pharma Recent Developments
- 4.2 Amneal Pharmaceuticals
- 4.2.1 Amneal Pharmaceuticals Company Information
- 4.2.2 Amneal Pharmaceuticals Business Overview
- 4.2.3 Amneal Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Pharmaceuticals Risperidone Product Portfolio
- 4.2.5 Amneal Pharmaceuticals Recent Developments
- 4.3 Apotex
- 4.3.1 Apotex Company Information
- 4.3.2 Apotex Business Overview
- 4.3.3 Apotex Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Apotex Risperidone Product Portfolio
- 4.3.5 Apotex Recent Developments
- 4.4 Aurobindo Pharma
- 4.4.1 Aurobindo Pharma Company Information
- 4.4.2 Aurobindo Pharma Business Overview
- 4.4.3 Aurobindo Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aurobindo Pharma Risperidone Product Portfolio
- 4.4.5 Aurobindo Pharma Recent Developments
- 4.5 Celltrion
- 4.5.1 Celltrion Company Information
- 4.5.2 Celltrion Business Overview
- 4.5.3 Celltrion Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Celltrion Risperidone Product Portfolio
- 4.5.5 Celltrion Recent Developments
- 4.6 Dr. Reddy's Laboratories
- 4.6.1 Dr. Reddy's Laboratories Company Information
- 4.6.2 Dr. Reddy's Laboratories Business Overview
- 4.6.3 Dr. Reddy's Laboratories Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dr. Reddy's Laboratories Risperidone Product Portfolio
- 4.6.5 Dr. Reddy's Laboratories Recent Developments
- 4.7 Hikma
- 4.7.1 Hikma Company Information
- 4.7.2 Hikma Business Overview
- 4.7.3 Hikma Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Risperidone Product Portfolio
- 4.7.5 Hikma Recent Developments
- 4.8 Lannett
- 4.8.1 Lannett Company Information
- 4.8.2 Lannett Business Overview
- 4.8.3 Lannett Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lannett Risperidone Product Portfolio
- 4.8.5 Lannett Recent Developments
- 4.9 Luye Pharma Group
- 4.9.1 Luye Pharma Group Company Information
- 4.9.2 Luye Pharma Group Business Overview
- 4.9.3 Luye Pharma Group Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Luye Pharma Group Risperidone Product Portfolio
- 4.9.5 Luye Pharma Group Recent Developments
- 4.10 Torrent Pharmaceuticals
- 4.10.1 Torrent Pharmaceuticals Company Information
- 4.10.2 Torrent Pharmaceuticals Business Overview
- 4.10.3 Torrent Pharmaceuticals Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Torrent Pharmaceuticals Risperidone Product Portfolio
- 4.10.5 Torrent Pharmaceuticals Recent Developments
- 4.11 Tris Pharma
- 4.11.1 Tris Pharma Company Information
- 4.11.2 Tris Pharma Business Overview
- 4.11.3 Tris Pharma Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Tris Pharma Risperidone Product Portfolio
- 4.11.5 Tris Pharma Recent Developments
- 4.12 Janssen (Johnson & Johnson)
- 4.12.1 Janssen (Johnson & Johnson) Company Information
- 4.12.2 Janssen (Johnson & Johnson) Business Overview
- 4.12.3 Janssen (Johnson & Johnson) Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Janssen (Johnson & Johnson) Risperidone Product Portfolio
- 4.12.5 Janssen (Johnson & Johnson) Recent Developments
- 4.13 Sandoz
- 4.13.1 Sandoz Company Information
- 4.13.2 Sandoz Business Overview
- 4.13.3 Sandoz Risperidone Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sandoz Risperidone Product Portfolio
- 4.13.5 Sandoz Recent Developments
5 Global Risperidone Market Scenario by Region
- 5.1 Global Risperidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Risperidone Sales by Region: 2021-2032
- 5.2.1 Global Risperidone Sales by Region: 2021-2026
- 5.2.2 Global Risperidone Sales by Region: 2027-2032
- 5.3 Global Risperidone Revenue by Region: 2021-2032
- 5.3.1 Global Risperidone Revenue by Region: 2021-2026
- 5.3.2 Global Risperidone Revenue by Region: 2027-2032
- 5.4 North America Risperidone Market Facts & Figures by Country
- 5.4.1 North America Risperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Risperidone Sales by Country (2021-2032)
- 5.4.3 North America Risperidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Risperidone Market Facts & Figures by Country
- 5.5.1 Europe Risperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Risperidone Sales by Country (2021-2032)
- 5.5.3 Europe Risperidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Risperidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Risperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Risperidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Risperidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Risperidone Market Facts & Figures by Country
- 5.7.1 South America Risperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Risperidone Sales by Country (2021-2032)
- 5.7.3 South America Risperidone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Risperidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Risperidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Risperidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Risperidone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Risperidone Sales by Type (2021-2032)
- 6.1.1 Global Risperidone Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Risperidone Sales Market Share by Type (2021-2032)
- 6.2 Global Risperidone Revenue by Type (2021-2032)
- 6.2.1 Global Risperidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Risperidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Risperidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Risperidone Sales by Application (2021-2032)
- 7.1.1 Global Risperidone Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Risperidone Sales Market Share by Application (2021-2032)
- 7.2 Global Risperidone Revenue by Application (2021-2032)
- 7.2.1 Global Risperidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Risperidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Risperidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Risperidone Value Chain Analysis
- 8.1.1 Risperidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Risperidone Production Mode & Process
- 8.2 Risperidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Risperidone Distributors
- 8.2.3 Risperidone Customers
9 Global Risperidone Analyzing Market Dynamics
- 9.1 Risperidone Industry Trends
- 9.2 Risperidone Industry Drivers
- 9.3 Risperidone Industry Opportunities and Challenges
- 9.4 Risperidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst